Compare ECOR & DH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECOR | DH |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.3M | 112.1M |
| IPO Year | 2018 | 2021 |
| Metric | ECOR | DH |
|---|---|---|
| Price | $7.17 | $1.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 7 |
| Target Price | ★ $19.17 | $1.63 |
| AVG Volume (30 Days) | 67.9K | ★ 330.0K |
| Earning Date | 11-04-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.28 |
| EPS | ★ N/A | N/A |
| Revenue | $32,032,000.00 | ★ $241,521,000.00 |
| Revenue This Year | $30.85 | N/A |
| Revenue Next Year | $29.71 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 27.20 | N/A |
| 52 Week Low | $4.41 | $0.61 |
| 52 Week High | $12.70 | $3.00 |
| Indicator | ECOR | DH |
|---|---|---|
| Relative Strength Index (RSI) | 36.60 | 64.37 |
| Support Level | $6.94 | $1.00 |
| Resistance Level | $8.26 | $1.14 |
| Average True Range (ATR) | 0.69 | 0.07 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 26.75 | 66.71 |
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.